Final Programme

Postgraduate Educational Programme
A-313 09:00
B. Plaque imaging with MR
J. Barkhausen; Essen/DE
Learning Objectives:
1. To demonstrate the methods of plaque imaging with MRI.
2. To understand the advantages and limitations of plaque imaging using MRI.
3. To discuss the clinical relevance of plaque imaging by MRI.
A-314 09:30
C. Calcium scoring: What does it mean?
R. Vliegenthart, M. Oudkerk; Groningen/NL
Learning Objectives:
1. To understand the shortcomings of coronary risk assessment based on cardiovascular risk factors.
2. To discuss the current evidence on the predictive value of coronary events when calcium scoring is added
to risk factor assessment.
3. To appreciate the validation of EBT and MDCT for calcium scoring.
4. To discuss the possible role of calcium scoring in cardiovascular risk assessment.
08:30 - 10:00 Room F2
Neuro
RC 1311
Diffusion and perfusion MR imaging of the brain
Moderator: P. Barsi; Páty/HU
A-315 08:30
A. Imaging technique and protocols, post-processing
L. Østergaard; Århus/DK
Learning Objectives:
1. To understand the problems and merits of the most common perfusion imaging techniques.
2. To discuss necessary features for imaging protocols.
3. To understand the basics of perfusion post-processing and its limitations.
4. To discuss various pitfalls that may lead to false interpretation of perfusion weighted images.
A-316 09:00
B. Clinical applications of diffusion and perfusion MRI of the brain
S. Arnold, P. Reimer; Karlsruhe/DE
Learning Objectives:
1. To learn about the most common clinical applications of diffusion imaging and perfusion imaging in neuro
MRI.
2. To understand the rationale for adding diffusion imaging and perfusion imaging to morphological MRI.
3. To value diffusion imaging and perfusion imaging in the scenario of a comprehensive neuro MRI
examination.
A-317 09:30
C. Diffusion tensor imaging and fi bre tracking
D. Prayer; Vienna/AT
Learning Objectives:
1. To understand the concept behind DTI and fi ber tracking.
2. To discuss the quantitative parameters derived from DTI.
3. To identify the potential uses of these parameters in clinical studies.
218 A B C D European Society of Radiology